These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26561839)

  • 1. [The diagnosis of latent tuberculosis infection in children in XXI century. Is tuberculin skin test still up to date?].
    Bielecka T; Komorowska-Piotrowska A; Mazur A; Feleszko W
    Postepy Hig Med Dosw (Online); 2015 Oct; 69():1130-9. PubMed ID: 26561839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.
    Starke JR;
    Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon gamma release assays: principles and practice.
    Lalvani A; Pareek M
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon-gamma release assays for hospital-based tuberculosis diagnostics in children and adolescents--a retrospective analysis].
    Knappik M; Schönfeld N; Günther A; Bergmann T; Magdorf K; Rüssmann H; Mauch H; Barker M
    Pneumologie; 2012 Apr; 66(4):207-11. PubMed ID: 22477480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Immune Response to Interferon Gamma Release Assay and Tuberculin Skin Test Among BCG Vaccinated Children in East of Egypt: A Cross-Sectional Study.
    Beshir MR; Zidan AE; El-Saadny HF; Ramadan RA; Karam NA; Amin EK; Mohamed MZ; Abdelsamad NM
    Medicine (Baltimore); 2016 Apr; 95(17):e3470. PubMed ID: 27124042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mycobacterium tuberculosis infection: signification, role and performance of mesure of cell-mediated immune response].
    Glardon D; Erard V
    Rev Med Suisse; 2014 Apr; 10(425):816-9. PubMed ID: 24791428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the QuantiFERON®-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.
    Pourakbari B; Yousefi K; Mahmoudi S; Sadeghi RH; Mamishi S
    Infect Disord Drug Targets; 2019; 19(2):141-144. PubMed ID: 29493468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with "positive" tuberculin skin test (≥10 mm).
    Gudjónsdóttir MJ; Kötz K; Nielsen RS; Wilmar P; Olausson S; Wallmyr D; Trollfors B
    BMC Infect Dis; 2016 Oct; 16(1):540. PubMed ID: 27716176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
    Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis Infection in Children and Adolescents: Testing and Treatment.
    Nolt D; Starke JR
    Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34851422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis skin test, but not interferon-γ-releasing assays is affected by BCG vaccination in HIV patients.
    Wolf T; Goetsch U; Oremek G; Bickel M; Khaykin P; Haberl A; Bellinger O; Gottschalk R; Brodt HR; Stephan C
    J Infect; 2013 Apr; 66(4):376-80. PubMed ID: 23159357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can ELISpot replace the tuberculin skin test for latent tuberculosis?
    Greveson K
    Br J Nurs; 2009 Nov 12-25; 18(20):1248-54. PubMed ID: 20081663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.